Carlsmed, Inc. (CARL): Cost of Revenue
$12.47M
Year ended 2025-12-31
$14.79M
Trailing 12 months to 2026-06-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.47M | +75.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $7.12M | n/a | 2026-02-25, From 2024-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Carlsmed, Inc. (CARL) | 2025-12-31 | $12.47M | +75.2% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $19.80M | +5.6% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $11.12M | +52.6% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $6.96M | +69.8% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $8.31M | -0.3% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $10.08M | +24.7% |
| LENSAR, Inc. (LNSR) | 2025-12-31 | $31.31M | +13.3% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $22.94M | +88.1% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $42.63M | -33.0% |
Compare CARL, APYX, SI, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗